From Staff Reports
KANNAPOLIS â Through her participation in COVID-19 research with the Duke Clinical and Translational Science Institute (CTSI), Connelia Houston learned about a new study in Kannapolis for people of African descent.
The Duke APOL1 Study at the N.C. Research Campus needs people like Houston who are 50 or older, have African ancestry and do not have kidney disease, diabetes or HIV. Houston, an attorney in Charlotte who lives in Harrisburg, decided to enroll.
âI was interested in this study due to my African ancestry, and I was so very pleasantly surprised at how easy everything was,â Houston said. âI felt great after I did it.âÂ
The doctor s office of the future will have an AI listening in yahoo.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from yahoo.com Daily Mail and Mail on Sunday newspapers.
Axios
Apr 17, 2021 5:35 PM ET
If note-taking could become automated, it would likely be a huge help to overworked medical professionals suffering from burnout after spending hours manually entering data at the end of their workdays.
But the real value comes in via data captured in doctors conversations with patients or written case notes. These AI models can extract information and then contextualize it in ways that doctors can act on, says Duane A. Mitchell, director of the University of Florida Clinical and Translational Science Institute.
Details: For example, while identifying the right set of patients to enroll in clinical trials would usually take weeks of manually extracting information from databases, the AI models could do the work within minutes, says Mona Flores, global head of AI at Nvidia.
Biologics Clinical Research: The Year s Best
Harry Selker, M.D. sits down with BioProcess Online for a candid discussion on the Clinical Research Forum’s work, its recognition of advances in clinical and translational research, and why that’s such an important structural element in the bridge between academia and industry.
As distinguished careers go, that of Harry Selker, M.D. is one virtually any academia-minded med student might aspire to. Currently Dean of Tufts Clinical and Translational Science Institute (CTSI) and Chair of the Clinical Research Forum, Dr. Selker’s 35-year run at Tufts started when he came to Tufts Medical Center after completing his training. He earned his M.D. at Brown University, did his residency at Boston City Hospital and was Chief Medical Resident at Boston University Medical Center/University Hospital, and then was a Robert Wood Johnson Clinical Scholarship at UCLA School of Medicine. Soon after joining Tufts, his roles their blossomed into Div
Duke CTSI launches kidney disease study in Kannapolis for people with African ancestry The Duke APOL1 Study at the N.C. Research Campus needs people who are 50 and older, have African ancestry and do not have kidney disease, diabetes or HIV. (Source: Duke CTSI) By David Whisenant | April 15, 2021 at 6:26 AM EDT - Updated April 15 at 6:37 AM
KANNAPOLIS, N.C. (WBTV) -
From Duke CTSI: Through her participation in COVID-19 research with the Duke Clinical and Translational Science Institute (CTSI), Connelia Houston learned about a new study in Kannapolis for people of African descent.
The Duke APOL1 Study at the N.C. Research Campus needs people like Houston who are 50 or older, have African ancestry and do not have kidney disease, diabetes or HIV. Houston, an attorney in Charlotte who lives in Harrisburg, decided to enroll.